A joint Delhi-Haryana enforcement team uncovered an alleged illegal drug unit in a Narela flat. The seizure has raised fresh alarm over counterfeit medicines and steroid distribution in the capital.
The Delhi Drugs Control Department, along with the Food and Drug Administration, Haryana, and Delhi Police, has busted an alleged illegal drug manufacturing and stocking racket operating from a residential apartment in Delhi, seizing suspected counterfeit medicines, anabolic steroids, raw materials and manufacturing equipment, officials said on Tuesday. According to a Delhi government statement, the two-day operation was carried out after specific intelligence about the suspected movement of spurious medicines from the premises.
Officials said the first day of the raid led to the detection of an unlicensed manufacturing and packaging unit inside the apartment in outer Delhi’s Narela. During the inspection, the occupant of the flat told officials that the premises had been rented for stocking and packaging allopathic medicines and claimed the operation was being run by another individual allegedly linked to a manufacturing facility in Haryana’s Sonipat. However, officials said no drug licence, purchase records or stock registers could be produced.
The team recovered sealing machines, hand-operated seal crimping devices, heat guns, electric stirrers, precision weighing scales, industrial filter paper, glass beakers, rubber closures and flip-off caps. Thousands of unlabelled tablets suspected to be Tofacitinib, liquid vials of anabolic steroids, including Boldenone, Masteron and Testosterone variants, and chemical solutions used in drug preparation were also seized, the statement said.
Acting on fresh intelligence, the joint team returned to the apartment complex the following day and searched common utility areas, leading to the recovery of additional consignments concealed inside electric utility shafts on multiple floors. The recovered stock included bulk steroid hormone powders such as Progesterone, Oxandrolone, Mesterolone and Trenbolone Enanthate, over 1,500 finished steroid injection vials carrying “Made in Germany” markings, more than 5,000 loose tablets, over 5,000 empty glass and amber vials, nearly 2,500 packaging boxes, thousands of flip-off caps and several documents believed to be linked to the alleged illegal operation.